Debt-to-equity of REVIVA PHARMACEUTICALS HOLDINGS, INC. from 31 May 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
REVIVA PHARMACEUTICALS HOLDINGS, INC. quarterly Debt-to-equity in % history and change rate from 31 May 2019 to 30 Sep 2025.
  • REVIVA PHARMACEUTICALS HOLDINGS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 10855%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 10855% +11409% 30 Sep 2025
Q2 2025 -397% +53% +12% 30 Jun 2025
Q1 2025 -295% +336% +53% 31 Mar 2025
Q4 2024 -370% +468% +56% 31 Dec 2024
Q3 2024 -554% +608% +52% 30 Sep 2024
Q2 2024 -450% -613% -376% 30 Jun 2024
Q1 2024 -631% -706% -937% 31 Mar 2024
Q4 2023 -838% -878% -2182% 31 Dec 2023
Q3 2023 -1162% -1183% -5596% 30 Sep 2023
Q2 2023 163% +150% +1149% 30 Jun 2023
Q1 2023 75% +67% +758% 31 Mar 2023
Q4 2022 40% +32% +374% 31 Dec 2022
Q3 2022 21% +9.3% +79% 30 Sep 2022
Q2 2022 13% -20% -60% 30 Jun 2022
Q1 2022 8.8% +202% 31 Mar 2022
Q4 2021 8.5% +86% 31 Dec 2021
Q3 2021 12% +70% 30 Sep 2021
Q2 2021 33% +124% 30 Jun 2021
Q1 2021 -193% +140% +42% 31 Mar 2021
Q4 2020 -77% -242% -147% 31 Dec 2020
Q3 2020 -58% -157% -159% 31 Aug 2020
Q2 2020 -91% -190% -192% 31 May 2020
Q1 2020 -333% 29 Feb 2020
Q4 2019 165% 31 Dec 2019
Q3 2019 99% 31 Aug 2019
Q2 2019 99% 31 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.